Image 1
Etodolac Tablet, Film Coated, Extended Release
Product Images NDC 0093-7172
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 0093-7172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This appears to be a label or packaging information for a medication called Etodolac Extended-Release Tablets. The product is USP certified and may have a serialization code area labeled "no coms3 112201." The manufacturer may be Teva.*
Image 3
This is a label of Etodolac Extended-Release Tablets, USP with a serialization coding area Nocons3 717201. It comes in a bottle containing 100 tablets manufactured by Teva.*
Image 4
This appears to be a label or packaging information for Etodolac Extended-Release Tablets, USP manufactured by Teva. The label includes the product name, dosage strength (100 tablets), and lot number (NoCo0s3 111801). The term "Seralization Coding Area" may refer to a specific area designated for product identification or tracking purposes in the manufacturing process.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
